Company profile
ASPIRE-FTD
Aspire-FTD - A clinical trial for frontotemporal dementia with GRN mutations - Information for people with FTD and their caregivers
Updated 07 Jul 2026 09:49
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
TM01 | Transaction MzUxMzk2OTA3MWFkaXF6a2N4
Published 01 Apr 2026 20:03
AP01 | Transaction MzUxMzk2OTA2OWFkaXF6a2N4
Published 01 Apr 2026 20:03
Last confirmation statement made up date
Last accounts made up date
SH01 | Transaction MzQ0MTg5NzQxNGFkaXF6a2N4 | Paper/PDF filed
Published 05 Nov 2024 07:14
RESOLUTIONS | Transaction WURFNlQ5U1dhZGlxemtjeA | Paper/PDF filed
Published 28 Oct 2024 06:41
MA | Transaction MzQ0MDI4Nzc2NmFkaXF6a2N4 | Paper/PDF filed
Published 28 Oct 2024 06:40
Company registered at Companies House
AviadoBio develops gene therapy treatments for neurodegenerative diseases.
Have raised £3m from charitable sources and made great progress in generating unencumbered intellectual property.
None yet as just formed
